vimarsana.com

Latest Breaking News On - Investor reception - Page 1 : vimarsana.com

Centergy awards excellence, successes at inaugural Investor Reception

Altimmune Announces Oral Presentation of Pemvidutide Clinical Data in Treatment of NAFLD at Upcoming EASL International Liver Congress™ 2023 - Altimmune (NASDAQ:ALT)

Presentation Selected for Best of EASL Summary Slides Altimmune to Host a NASH KOL and Investor Reception on June 22, 2023 GAITHERSBURG, Md., June 15, 2023 (GLOBE NEWSWIRE) Altimmune, Inc. (NASDAQ:ALT), a

Investors, pump up your pipeline at TechCrunch Disrupt

Investors, learn about all the ways to fill your pipeline and grow your network at TechCrunch Disrupt. Be the first to meet the Startup Battlefield 200 companies. Plus investor sessions, receptions and networking opportunities.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.